What's new? Log in Free sign up

Filing search / Nkarta, Inc. / "Retention"

Search information

Nkarta, Inc.

Companies

"Retention"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

30 results

Newest first Best match first

NKTX Nkarta, Inc.

Quarterly report

for the treatment of autoimmune disease. Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be delayed … of patients in our clinical trials. For further details about such reasons, see “—Enrollment and retention of patients in clinical trials

13 Aug 24

4:08pm

NKTX Nkarta, Inc.

Quarterly report

-targeted therapies for the treatment of autoimmune disease. Enrollment and retention of patients in clinical trials is an expensive and time-consuming … , which may impact our ability to successfully develop and commercialize NKX019. For further details about such reasons, see “—Enrollment and retention

9 May 24

4:14pm

NKTX Nkarta, Inc.

. Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be delayed, made more difficult or rendered … to successfully develop and commercialize NXK019. For further details about such reasons, see “—Enrollment and retention of patients in clinical trials

21 Mar 24

4:23pm

NKTX Nkarta, Inc.

Quarterly report

and retention of patients in clinical trials is an expensive and time-consuming process and could be delayed, made more difficult or rendered … candidate we develop, we may be unable to obtain approval of or market our product candidates. Enrollment and retention of patients in clinical

9 Nov 23

4:19pm

NKTX Nkarta, Inc.

Quarterly report

. Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be delayed, made more difficult … with any product candidate we develop, we may be unable to obtain approval of or market our product candidates. Enrollment and retention of patients

10 Aug 23

7:15am

Quarterly report

11 May 23

4:19pm

Quarterly report

9 Nov 22

4:10pm

Quarterly report

11 Aug 22

4:20pm

Quarterly report

12 May 22

4:25pm

17 Mar 22

4:21pm

i3ocxke71l vquoir2h1

Quarterly report

10 Nov 21

4:32pm

3sg6cx4oof6rk ok

Shelf registration

Shelf registration

Quarterly report

12 Aug 21

4:37pm

Quarterly report

12 Aug 21

4:37pm

m2ogr3hvbt7c68week21

Entry into a Material Definitive Agreement

Quarterly report

13 May 21

4:25pm

Quarterly report

20lrjmzenvqj29jhbfr5

Prospectus supplement with pricing info

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.